Nurix Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 623,605 | 1.05% |
Individual Insiders | 708,512 | 1.19% |
VC/PE Firms | 2,997,830 | 5.05% |
Hedge Funds | 7,138,644 | 12% |
General Public | 13,701,405 | 23.1% |
Institutions | 34,147,465 | 57.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 25%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
4,643,736 | US$63.1m | 2.77% | no data | |||
3,882,125 | US$52.7m | 0% | 0.69% | |||
3,256,519 | US$44.2m | 14.3% | 1.86% | |||
3,099,098 | US$42.1m | 1,220% | 0.01% | |||
2,997,830 | US$40.7m | 0% | 1.44% | |||
2,635,338 | US$35.8m | -17.5% | 0.29% | |||
2,598,097 | US$35.3m | -4.3% | no data | |||
2,389,966 | US$32.5m | 0.5% | no data | |||
1,822,883 | US$24.8m | 0% | 2.44% | |||
1,236,753 | US$16.8m | -55% | 0.07% | |||
1,080,523 | US$14.7m | 3.37% | no data | |||
1,000,044 | US$13.6m | 4.38% | no data | |||
921,322 | US$12.5m | -48.1% | no data | |||
918,110 | US$12.5m | -5.16% | 0.04% | |||
773,588 | US$10.5m | -13.8% | 0.01% | |||
717,654 | US$9.7m | 0% | 0.9% | |||
690,112 | US$9.4m | 176% | 2.28% | |||
622,297 | US$8.5m | 0% | no data | |||
532,475 | US$7.2m | -19.7% | no data | |||
504,205 | US$6.8m | 2,470% | no data | |||
416,814 | US$5.7m | -5.45% | no data | |||
377,588 | US$5.1m | 31% | no data | |||
357,287 | US$4.9m | 0% | 0.01% | |||
323,729 | US$4.4m | 0.88% | no data | |||
314,762 | US$4.3m | 0% | 0.05% |